Toringin

Toringin
Product Name Toringin
CAS No.: 1329-10-8
Catalog No.: CFN93126
Molecular Formula: C21H20O9
Molecular Weight: 416.38 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Powder
Targets: Caspase
Source: The herbs of Malus spectabilis
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price:
Toringin prevents the cis-effect of expanded CTG repeats in a stable PC12 cell transformant.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Bulletin of Health Research2016, 44(4):279-286
  • Molecules.2020, 25(21):5087.
  • J Phys Chem Lett.2021, 12(7):1793-1802.
  • PLoS One.2021, 16(9):e0257243.
  • Journal of Ginseng Research2024, 03.005.
  • Anticancer Res.2014, 34(7):3505-9
  • American Association for Anatomy2020, doi: 10.1002.
  • Heliyon2022, 8(2):e08866.
  • Trop J Nat Prod Res, February2023, 7(2):2371-2381
  • Pharmaceutics.2023, 15(9):2355.
  • Isoquercitrin

    Catalog No: CFN98753
    CAS No: 482-35-9
    Price: $40/20mg
    Tanshinone I

    Catalog No: CFN98953
    CAS No: 568-73-0
    Price: $30/20mg
    Isovitexin 2''-O-arabinoside

    Catalog No: CFN90943
    CAS No: 53382-71-1
    Price: $318/10mg
    6',7'-Dihydroxybergamottin

    Catalog No: CFN98307
    CAS No: 264234-05-1
    Price: $318/10mg
    Glycycoumarin

    Catalog No: CFN89408
    CAS No: 94805-82-0
    Price: $268/10mg
    Biochem Pharmacol. 2005 Feb 1;69(3):503-16.
    Some flavonoids and DHEA-S prevent the cis-effect of expanded CTG repeats in a stable PC12 cell transformant.[Pubmed: 15652241]
    Expanded CUG triplet repeats carrying mRNA seem to be responsible for myotonic dystrophy type 1 (DM1). To study the pathogenesis of DM1, we constructed a DM1 cell culture model using a PC12 neuronal cell line and screened flavonoids that ameliorate this mRNA gain of function.
    METHODS AND RESULTS:
    The expanded 250 CTG repeat was subcloned into the 3'-untranslated region of the luciferase gene yielding a stable transformant of PC12 (CTG-250). The cytotoxicity of CTG-250 was evaluated by intracellular LDH activity, and the cis-effect by luciferase activity. To find agents that alter CTG-250 toxic effects, 235 bioflavonoids were screened. An increased cis-effect and cytotoxicity were found when CTG-250 was treated with nerve growth factor to induce differentiation. Western blotting with anti-caspase-3 antibody suggested that cell death was caused by apoptosis. Screening analysis confirmed that a flavone (Toringin), an isoflavones (genistein and formononetin), a flavanone (isosakuranetin), and DHEA-S prevent both the cytotoxicity and cis-effect of CTG-250 and that a flavanone (naringenin), isoflavone (ononin), and xanthylatin strongly inhibit the cis-effect of CTG repeats.
    CONCLUSIONS:
    In conclusion, we found that this neuronal cell line, which expresses the CUG repeat-bearing mRNA, showed cis-effects through the reporter gene and neuronal death after cell differentiation in vitro. However, some flavonoids and DHEA-S inhibit both the cis-effect and cytotoxicity, indicating that their chemical structures work to ameliorate both these toxic effects. This system makes it easy to evaluate the toxic effects of expanded CTG repeats and therefore should be useful for screening other DM1 treatments for their efficacies.
    Lanceolarin

    Catalog No: CFN95166
    CAS No: 15914-68-8
    Price: $318/5mg
    Japondipsaponin E1

    Catalog No: CFN95354
    CAS No: 175586-66-0
    Price: $318/5mg
    Toddalolactone 3'-O-methyl ether (6-(2-Hydroxy-3-methoxy-3-methylbutyl)-5,7-dimethoxycoumarin)

    Catalog No: CFN95372
    CAS No: 143614-35-1
    Price: $318/10mg
    7-Oxodehydroabietic acid

    Catalog No: CFN95411
    CAS No: 18684-55-4
    Price: $318/5mg
    threo-Guaiacylglycerol-beta-coniferyl aldehyde ether

    Catalog No: CFN95417
    CAS No: 650600-33-2
    Price: $318/5mg
    Isosecotanapartholide

    Catalog No: CFN95471
    CAS No: 102926-01-2
    Price: $318/10mg
    Giganteone A

    Catalog No: CFN95481
    CAS No: 460337-13-7
    Price: $318/5mg
    (R)-Mucronulatol

    Catalog No: CFN95492
    CAS No: 57128-11-7
    Price: $318/10mg
    Caffeoylcalleryanin

    Catalog No: CFN95532
    CAS No: 20300-49-6
    Price: $318/10mg
    Symplocoside

    Catalog No: CFN95552
    CAS No: 76502-76-6
    Price: $318/5mg